Is right ventricular outflow tract epicardial substrate ablation the standard of care in high-risk Brugada syndrome?
Elijah R Behr, Giulio Conte, Arthur Wilde · 2024
Read Is right ventricular outflow tract epicardial substrate ablation the standard of care in high-risk Brugada syndrome? by Elijah R Behr, Giulio Conte, Arthur Wilde (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-10824472.txt.
Description
Elijah Behr, Giulio Conte, and Arthur Wilde ask, in a 2024 editorial, whether burning away abnormal heart tissue should now be standard care for the riskiest patients with Brugada syndrome. The inherited condition can trigger lethal rhythms without warning. Current European guidance says the procedure, ablation, should be considered when shocks from an implanted defibrillator keep recurring despite drugs.
The editorial weighs the newest evidence, a study of high-risk patients plus a large registry of 159 treated patients. In the registry, 81 percent stayed free of dangerous rhythms after one procedure, and 96 percent after a second. The target tissue sits on the outer wall of the heart's right side, scarred beneath the surface. The authors trace the technique's history and its supporting studies. Their question is whether results this strong should move ablation from an option to the expected path.
Catalog record
| CREATOR | Elijah R Behr, Giulio Conte, Arthur Wilde |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 10 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |